KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Net Cash Flow (2016 - 2025)

Merck (MRK) has disclosed Net Cash Flow for 17 consecutive years, with -$3.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 258.23% to -$3.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $809.0 million, a 87.93% decrease, with the full-year FY2025 number at $809.0 million, down 87.93% from a year prior.
  • Net Cash Flow was -$3.6 billion for Q4 2025 at Merck, down from $10.2 billion in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $10.2 billion in Q3 2025 to a low of -$4.7 billion in Q1 2025.
  • A 5-year average of $321.9 million and a median of -$250.5 million in 2022 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: crashed 2155.29% in 2021, then soared 245.29% in 2024.
  • Merck's Net Cash Flow stood at -$1.7 billion in 2021, then skyrocketed by 164.57% to $1.1 billion in 2022, then plummeted by 272.52% to -$1.9 billion in 2023, then skyrocketed by 48.46% to -$1.0 billion in 2024, then plummeted by 258.23% to -$3.6 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Net Cash Flow are -$3.6 billion (Q4 2025), $10.2 billion (Q3 2025), and -$1.0 billion (Q2 2025).